Related Experiment Video
Updated: Jun 7, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes
Jeroen de Bresser1, Yael D Reijmer, Esther van den Berg
1Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands. J.deBresser@umcutrecht.nl
Background/Aims:
The present study examined the relationship between microvascular complications and cognitive decline and the development of structural brain abnormalities over a period of 4 years in patients with type 2 diabetes mellitus (T2DM).
Methods:
Sixty-eight elderly patients with T2DM had 2 cognitive assessments with a 4-year interval. Two MRI scans, performed at the same time as the cognitive assessments, were available from 55 patients. Changes in cognitive performance over time were expressed as a regression-based index (RBI). Automated volumetric measurements of total brain, lateral ventricles and white matter hyperintensities were performed. The relationship between baseline microvascular complications [diabetic retinopathy, peripheral neuropathy or albuminuria (micro- or macroalbuminuria)] and cognition and brain volumes was examined with linear regression analyses adjusted for age and sex (for cognition also for IQ).
Results:
At baseline, diabetic retinopathy was present in 18% of patients, peripheral neuropathy in 36%, albuminuria in 15%. Retinopathy or neuropathy were not significantly associated with baseline cognition or brain volumes, or changes in these measures over time. Albuminuria was associated with a lower composite RBI score, indicating accelerated cognitive decline (adjusted mean difference between patients with or without albuminuria: -0.58, 95% CI -0.85 to -0.31, p < 0.001).
Conclusion:
Albuminuria predicted accelerated cognitive decline in patients with T2DM, but other microvascular complications were unrelated to accelerated cognitive decline or brain MRI abnormalities.
Insights
In patients with type 2 diabetes mellitus (T2DM), albuminuria predicted faster cognitive decline over four years. Other microvascular complications like retinopathy or neuropathy did not show this association.
Area of Science:
- Neurology
- Endocrinology
- Diabetology
Background:
- Type 2 diabetes mellitus (T2DM) is associated with microvascular complications.
- These complications may impact cognitive function and brain structure.
- Longitudinal studies are needed to clarify these relationships.
Purpose of the Study:
- To investigate the association between microvascular complications in T2DM and cognitive decline.
- To examine the relationship between these complications and structural brain changes over four years.
- To determine if diabetic retinopathy, peripheral neuropathy, or albuminuria predict cognitive decline or brain abnormalities.
Main Methods:
- Sixty-eight elderly T2DM patients underwent two cognitive assessments over four years.
- Brain MRI scans were analyzed for volumetric changes in total brain, ventricles, and white matter hyperintensities.
- Linear regression analyses assessed the relationship between baseline microvascular complications and cognitive/brain changes.
Main Results:
- Albuminuria was significantly associated with accelerated cognitive decline (p < 0.001).
- Diabetic retinopathy and peripheral neuropathy were not significantly linked to cognitive decline or brain abnormalities.
- No significant associations were found between microvascular complications and changes in brain volumes over time.
Conclusions:
- Albuminuria is a predictor of accelerated cognitive decline in individuals with T2DM.
- Other common microvascular complications, such as retinopathy and neuropathy, do not appear to influence cognitive decline or brain structure in this cohort.
- These findings highlight the importance of monitoring for albuminuria in T2DM patients to identify those at higher risk for cognitive impairment.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Dementia l: Introduction
Psychoneuroimmunology: Diabetes and Cancer
Diabetic Retinopathy
Alzheimer Disease l: Introduction

